 Precigen Inc NASDAQ: PGEN has agreed to sell its subsidiary Trans Ova Genetics, an animal reproductive technologies company, to URUS, a holding company with cooperative and private ownership. The deal consideration includes 170 million in upfront cash and up to 10 million earn-. 